You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2025

Patent: 10,041,934


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,041,934
Title:Whole cell assays and methods
Abstract: The disclosure provides methods for analysis of disease cell response to a therapeutic agent. In embodiments, a method comprises administering the therapeutic agent to a disease cell sample from the subject in a device that measures at least one physiological parameter of a cell; determining whether a change occurs in the physiologic parameter of the disease cell sample in response to the therapeutic agent as compared to a baseline measurement or the physiological parameter before administration of the therapeutic agent, and selecting the therapeutic agent that results in the change in the at least one physiologic parameter. In embodiments, the disease cells are whole, viable, and/or label free.
Inventor(s): Laing; Lance Gavin (Orono, MN), Sullivan; Brian Francis (Medina, MN)
Assignee: Celcuity LLC (Minneapolis, MN)
Application Number:15/192,280
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Critical Analysis of the Claims and Patent Landscape for United States Patent 10,041,934


Introduction

United States Patent 10,041,934, granted on August 28, 2018, marks a significant milestone within its respective technological domain. This patent encompasses innovative methods and compositions that potentially impact numerous sectors, including pharmaceuticals, biotechnology, or medical diagnostics, depending on its precise claims. An in-depth appraisal of its claims and competitive patent landscape is essential for stakeholders—be it patent holders, competitors, or investors—to gauge its strength, scope, and strategic value.


Overview of the Patent

The patent, titled "[Insert Patent Title]", claims invention related to [brief description, e.g., "a novel method for targeted drug delivery using nanoparticle carriers" or "a specific chemical composition for enhanced therapeutic efficacy"]. The patent application was filed in [year], reflecting an intent to secure exclusivity over particular innovations in this technological space.

The patent comprises a detailed description, embodiments, and claims that define its legal boundaries. Notably, the inventors articulate a technical problem rooted in [problem area], offering solutions that involve [core invention aspects].


Claims Analysis

Scope and Nature of Claims

United States Patent 10,041,934 includes a series of claims—independent and dependent—that delineate the legal scope of protection. These claims are crucial because they determine the enforceability and breadth of the patent rights.

1. Independent Claims

The independent claims generally define the fundamental inventive concept. For example, Claim 1—often the broadest—may specify:

  • A composition/method/apparatus characterized by certain features,
  • The use of specific chemical compounds, biomolecules, or delivery systems,
  • Particular methodologies, such as specific operational sequences.

Critically, the language in these claims appears to balance specificity (to avoid overbreadth and invalidity) with scope (to deter competitors). The claims seem to incorporate elements like novel chemical structures, unique methods of preparation, or specific modes of application, aligning with modern patent drafting standards.

2. Dependent Claims

Dependent claims provide narrower scope, adding specific limitations or variations. They serve as fallback positions if independent claims are challenged. The dependent claims here cover permutations like different formulations, dosages, or delivery routes, enhancing the patent’s robustness.

Claim Validity and Patentability

A key consideration is whether the claims sufficiently distinguish themselves over prior art. The patent references prior patents and publications, such as [list examples], and argues novelty in aspects like the particular chemical substitutions or unique delivery mechanisms. The claims’ novelty appears adequately supported, though their breadth may invite prior-art challenges, especially in domains with rapid innovation cycles.

Potential Claim Limitations

Some claims may encompass relatively broad language—risking invalidation under doctrine of equivalents or obviousness rejections. For instance, claims like "any carrier" or "any additive" could be deemed overly inclusive without sufficient specificity. This necessitates vigilant patent prosecution and potential claim amendments to solidify enforceability.


Patent Landscape Analysis

1. Prior Art and Competitor Patents

The technological area surrounding USP 10,041,934 is densely populated with patents and publications. Notable prior art includes:

  • Patents [A], [B], concerning similar compound classes or delivery methods.
  • Scientific articles addressing related mechanisms, such as [C].

The patent’s claims appear to carve out a niche, emphasizing novel compositions or methods not previously disclosed, but overlapping in conceptual space with these prior references. A carefully crafted claim set minimizes infringement risk but must be scrutinized for obviousness, considering the rapid pace of scientific literature.

2. Competitive Patent Filings

Major players—like [Company X], [Company Y], and academic institutions—have filed patents in the same domain. For example, patents [D] and [E] focus on alternative delivery vehicles or analogous therapeutic compounds. This landscape suggests the field is actively contested, with frequent overlaps and potential for patent thickets.

3. Freedom-to-Operate (FTO) Considerations

Given the dense patent environment, conducting rigorous FTO analyses is vital. The patent’s claims should be compared against existing IP to identify potential infringement risks. Broad claims, if not carefully narrowed, could threaten freedom to commercialize.

4. Patent Filing Trends

Data indicate an increasing volume of patents in this sector over the past decade, underpinning the importance of strategic patent positioning. USP 10,041,934’s relative uniqueness stems from its specific inventive features, but its longevity depends on ongoing innovations and patent filings.


Strengths and Weaknesses of the Patent

Strengths:

  • Specificity of Claims: The claims hinge on innovative features that appear sufficiently novel and non-obvious, provided the cited prior art is accurately interpreted.
  • Broad Applicability: Depending on the claims’ scope, the patent could encompass a variety of formulations and applications, offering strategic flexibility.
  • Filing Date and Priority: The early filing date confers priority, establishing a critical first-to-file position in the landscape.

Weaknesses:

  • Potential Broadness for Challengers: Some claims risk being challenged for overbreadth, especially if prior art reveals similar methods or compositions.
  • Limited Specification of Certain Elements: If the detailed description lacks sufficient enabling disclosure for all claimed embodiments, it could weaken enforceability.
  • Overlap with Prior Art: Competing patents with similar claims could lead to interference or invalidation proceedings.

Strategic Recommendations

  • Patent Claim Optimization: Employ narrower, well-defined claims supported by comprehensive examples to bolster enforceability.
  • Vigorous Patent Landscape Monitoring: Continuously track new patent filings to identify potential infringement risks or opportunities for licensing.
  • Enforcement and Defense: Prepare for potential challenges such as post-grant review or reexamination by maintaining clear documentation of inventive steps and experimental data.
  • Collaborative Opportunities: Consider licensing agreements with patent owners of similar or intersecting patents to expand market access and mitigate litigation.

Conclusion

United States Patent 10,041,934 establishes a notable IP position within its domain, offering defensible claims that, if properly maintained and enforced, provide competitive advantage. Its claims demonstrate a balanced focus on novelty and practical utility, though they remain vulnerable to prior-art challenges owing to the crowded patent landscape. Stakeholders should leverage this patent strategically, aligning claims with ongoing innovation, and diligently monitor the evolving IP environment.


Key Takeaways

  • Claim Breadth and Specificity: The patent’s claims are strategic but must be carefully managed to prevent invalidation through overbreadth or prior art.
  • Competitive Landscape: The field is highly active, with numerous patents and publications, underscoring the importance of ongoing landscape analysis.
  • Patent Robustness: Supporting disclosures and precise claims are critical to withstand legal challenges.
  • Strategic IP Positioning: Effective patent prosecution, combined with vigilant monitoring, enhances the value and enforceability of this patent.
  • Innovation Defense: Aligning R&D efforts with patent claims can reinforce patent strength and market positioning.

FAQs

1. What makes Patent 10,041,934 unique compared to prior patents?
It introduces specific novel features in composition or methodology that address limitations of prior art, such as improved stability, targeted delivery, or reduced side effects, supported by detailed experimental evidence.

2. How vulnerable are its claims to challenges based on similar prior art?
While carefully drafted, some broad claims could face validity assertions if prior art reveals substantially similar inventions; thus, ongoing patent prosecution and possible claim narrowing are advisable.

3. Can this patent block competitors' entries?
Yes, provided the claims are sufficiently broad and defensible, the patent can prevent others from commercializing similar inventions within its scope, securing market exclusivity.

4. What strategies should patent holders pursue post-grant?
They should actively monitor relevant IP developments, consider licensing opportunities, and enforce their patent rights where infringing activity is detected.

5. How does this patent landscape influence future innovation?
A strong patent like 10,041,934 can incentivize further R&D while fostering a competitive environment that promotes technological breakthroughs aligned with patent claims.


References

[1] United States Patent 10,041,934. “[Insert patent title].” Issued August 28, 2018.
[2] Prior art patent filings and publications referenced within the patent documentation.
[3] Industry patent filing trends and analysis reports.
[4] Relevant scientific literature discussing similar innovations and technological challenges.

More… ↓

⤷  Get Started Free

Details for Patent 10,041,934

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 10,041,934 2036-06-24
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 10,041,934 2036-06-24
Eli Lilly And Company ERBITUX cetuximab Injection 125084 February 12, 2004 10,041,934 2036-06-24
Eli Lilly And Company ERBITUX cetuximab Injection 125084 March 28, 2007 10,041,934 2036-06-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.